← All Sponsors
SPONSOR

Shanghai Ruiliyuan Biotechnology Co., Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: Hepatic Cell Carcinoma
NCT06515314 Phase 1
Recruiting

HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors

Hepatic Cell Carcinoma
China View Trial →